Although colonic anti-inflammatory cytokine IL-10 levels were not significantly different between the colitis and the control rats, the CAP treated group significantly increased colonic IL-10 levels compared to the U group (p < 0.05) (Figure 5C). Here, IL10 is linked to colitis.